Satya Prakash Yadav/X
Aug 15, 2026, 16:00
Satya Prakash Yadav: Overcoming Overtreatment in Pediatric Immune Thrombocytopenia
Satya Prakash Yadav, Director of Pediatric Hemato-Oncology and Bone Marrow Transplant at Medanta, shared Blood Journals Portfolio’s post on X, adding։
“Immune thrombocytopenia (ITP) in children is most over treated disorder.
No treatment still remains best treatment for most patients!
Don’t be scared of low platelets – These platelets are fresh platelets, large in size and functionally more powerful then older platelets.”
Stay updated with Hemostasis Today.
-
Aug 15, 2026, 16:58Andrew Jackson: Oral Anticoagulants for the Prophylaxis of Catheter-Related Thrombosis
-
Aug 15, 2026, 16:52Understanding Blood Clots During Pregnancy and After Birth – Thrombosis UK
-
Aug 15, 2026, 16:39Liri Seraj: How Summer Dehydration Affects Blood and Thrombosis Risk
-
Aug 15, 2026, 16:29Denise Rezende: What Should Clinicians Do When Thrombosis Occurs Despite DOAC Therapy?
-
Aug 15, 2026, 16:20Anoop Singh: When India Became the Key to a Faster Hemophilia A Trial
-
Aug 15, 2026, 16:10Swarup K Chakrabarti: Why the Blood–Brain Barrier Matters for Healthy Aging
-
Aug 15, 2026, 15:54Clare Craig: Examining Post-Pandemic Healthcare Disruption and Thrombocytopenia Risks
-
Aug 15, 2026, 15:39Dee Sparacio: QI Initiative Reduces Venous Thromboembolism in First-Line Ovarian Cancer Care
-
Aug 15, 2026, 15:26Exploring Pediatric Pulmonary Infarction and Infarction-Like Injury – Seminars in Thrombosis and Hemostasis